Evidence map›Paper›PMID 28664455›Full record

ArticleMolecular neurobiology2018

Neuroprotective Effects of the Absence of JNK1 or JNK3 Isoforms on Kainic Acid-Induced Temporal Lobe Epilepsy-Like Symptoms.

Luisa de Lemos, Felix Junyent, Antoni Camins, Rubén Darío Castro-Torres, Jaume Folch, Jordi Olloquequi, Carlos Beas-Zarate, Ester Verdaguer, Carme Auladell

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Research progress on oxidative stress regulating different types of neuronal death caused by epileptic seizures.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Review
  7. Novel c-Jun N-Terminal Kinase (JNK) Inhibitors with an 11Molecules (Basel, Switzerland) · 2021
    Article
  8. DualInternational journal of molecular sciences · 2021
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 4 countries.

Luisa de LemosUnitat de Farmacologia i Farmacognòsia, Facultat de Farmàcia, Universitat de Barcelona, Avda Diagonal 641, E-08028, Barcelona, Spain.
Felix JunyentUnitat de Farmacologia i Farmacognòsia, Facultat de Farmàcia, Universitat de Barcelona, Avda Diagonal 641, E-08028, Barcelona, Spain.
Antoni CaminsUnitat de Farmacologia i Farmacognòsia, Facultat de Farmàcia, Universitat de Barcelona, Avda Diagonal 641, E-08028, Barcelona, Spain.
Rubén Darío Castro-TorresUnitat de Farmacologia i Farmacognòsia, Facultat de Farmàcia, Universitat de Barcelona, Avda Diagonal 641, E-08028, Barcelona, Spain.
Jaume FolchNetworking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Jordi OlloquequiFacultad de Ciencias de la Salud, Instituto de Ciencias Biomédicas, Universidad Autónoma de Chile, Talca, Chile.
Carlos Beas-ZarateLaboratorio de Regeneración Neural, Departamento de Biología Celular y Molecular, CUCBA, Universidad de Guadalajara, Guadalajara, Mexico.
Ester VerdaguerNetworking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Carme AuladellNetworking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain. cauladell@ub.edu.ORCID http://orcid.org/0000-0001-8345-1859
Instituto de Salud Carlos III · ESUniversidad de Guadalajara · MXBiomedical Research Networking Center on Neurodegenerative Diseases · ESInstituto Gulbenkian de Ciência · PTUniversidad Autónoma de Chile · CLUniversitat de Barcelona · ES

Funding

•Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED) CB06/05/0024•Consejo Nacional de Ciéncia y Tecnologia (CONACYT) 177594 (CBZ)Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya 2014SGR-525•MMinisterio Español de Ciéncia y Innovación PI2016/01
6 · The paper itself

Abstract

The activation of c-Jun-N-terminal kinases (JNK) pathway has been largely associated with the pathogenesis and the neuronal death that occur in neurodegenerative diseases. Altogether, this justifies why JNKs have become a focus of screens for new therapeutic strategies. The aim of the present study was to identify the role of the different JNK isoforms (JNK1, JNK2, and JNK3) in apoptosis and inflammation after induction of brain damage. To address this aim, we induced excitotoxicity in wild-type and JNK knockout mice (jnk1

Indexed as

AnimalsApoptosisEnzyme ActivationEpilepsy, Temporal LobeHippocampusInflammationIsoenzymesKainic AcidMice, Inbred C57BLMice, KnockoutMitogen-Activated Protein Kinase 10Mitogen-Activated Protein Kinase 8Neuroprotective AgentsPhosphorylationIsoenzymesKainic AcidMitogen-Activated Protein Kinase 10Mitogen-Activated Protein Kinase 8Neuroprotective Agentsc-Jun N-terminal kinaseExcitotoxicityHippocampusInflammationKainic acidKnockout miceNeurodegenerationNeuroprotection

Identifiers

PMID28664455
OpenAlexW2731123501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.